After 5 Years Cervical Cancer Vaccine Tested in Brazil and US Keeps Working

    Young woman gets a cervical cancer vaccine shot

    Young woman gets a cervical cancer vaccine shot As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress. While HPV vaccine efforts had the "benefit" of a viral source for the disease, other researchers are developing vaccines for cancers that are not virally based, in an effort to coax the immune system into attacking cancerous cells.

    Today at the 2007 Annual Meeting of the American Association for Cancer Research, presentations on ongoing HPV trials and other new approaches to stimulating the immune system are injecting momentum into cancer vaccine research.

    Ongoing evaluation of a phase II trial of a human papillomavirus vaccine, developed to prevent cervical cancer, shows that the vaccine continues to protect against HPV types 16 and 18 at five and a half years into the study, according to researchers from the University of Louisville. Their findings also show that the vaccine offers significant cross-protection for HPV types 45 and 31.

    The study follows 1113 women between the ages of 15 and 25 in North America and Brazil randomized to receive three doses of either the vaccine or the control. The vaccine, made by GlaxoSmithKline, which funded the study, is designed to protect against two strains of HPV, types 16 and 18, which together are thought to cause nearly 72 percent of all cases of cervical cancer.

    At over five years into the study’s follow-up, the researchers found that approximately 98 percent of subjects still maintained protection against HPV types 16 and 18. Regardless of HPV status, the vaccine also appears to prevent most occurrences of cervical intraepithelial neoplasia lesions – abnormal, precancerous cell growths found in the cervix.

    They also found that the vaccination offered significant protection against genetically similar viruses. They determined the vaccine to be 88 percent effective against HPV type 45 and 54 percent effective against HPV type 31.

    "Overall, it is not a surprise that the vaccine offers protection against additional types of human papillomavirus, as they are all related genetically," said Stanley Gall, M.D., professor at the University of Louisville. "However, as you get genetically farther from types 16 and 18, you would expect to see less cross-protection."

    According to Dr. Gall, effective preventative treatment with the vaccine will depend on the long-term and broad protection the vaccine can offer against cancer-causing HPV types.

    Tags:

    • Show Comments (0)

    Your email address will not be published. Required fields are marked *

    comment *

    • name *

    • email *

    • website *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Ads

    You May Also Like

    Brazil Getting 85,000 New Cases of Tuberculosis a Year

    Brazil managed to cure between 75% and 77% of the tuberculosis cases detected in ...

    Brazil's solidarity dolls join the fair trade movement

    Brazil Learns That Fair Trade Pays Off

    Brazil is turning into one of the world’s leading producers and consumers of Fair ...

    Brazilian racecar driver Vitor Meira

    Why This Brazilian Wunderkind Deserves to Win the Next Indy 500

    In one of the more inexplicable developments in recent Indianapolis 500 history Panther Racing ...

    Expert Wants Brazil to Take Urgent Measures Against Bird Flu

    Ricardo de Melo Martins, professor of medicine at the University of BrasÀ­lia (UnB), in ...

    Recent Events in Brazil Are Not an Excuse for Torture

    Amnesty International strongly condemns the reported rape of a female teacher held hostage during ...

    After 4 Deaths, Prison Warden Taken as Hostage by Brazilian Inmates

    A prison riot in Brazil’s remote Amazon jungle state of Rondônia has left four ...

    Brazilian embassy in Ottawa, Canada

    Brazil Adds Agricultural Attachí© to Its Embassies

    The Brazilian government is going to create the position of agricultural attaché at Brazil's ...

    Brazil's French bun

    Brazil Makes a Push to Become Wheat Self-Sufficient

    Main ingredient of pãozinho (crusty French bun), present on the tables of most Brazilian ...

    A Brazilian cargo train

    Brazil’s Trade Surplus in First Four Months 68% Better than Last Year’s

    Brazil's trade surplus (the difference between exports and imports) reached US$ 547 million in ...

    Brazil Has Strong Case Against Bolivia in International Court

    The Brazilian government has the option of going to court (the International Court of ...